These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 38515777)

  • 1. Nanotechnology-based delivery systems to overcome drug resistance in cancer.
    Patel H; Li J; Bo L; Mehta R; Ashby CR; Wang S; Cai W; Chen ZS
    Med Rev (2021); 2024 Feb; 4(1):5-30. PubMed ID: 38515777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
    Yadav P; Ambudkar SV; Rajendra Prasad N
    J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicines for combating multidrug resistance of cancer.
    Zhu YX; Jia HR; Duan QY; Wu FG
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1715. PubMed ID: 33860622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nanomedicines to overcome cancer multidrug resistance.
    Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
    Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can nanomedicines overcome cellular-based anticancer drug resistance?
    Sobot D; Mura S; Couvreur P
    J Mater Chem B; 2016 Aug; 4(30):5078-5100. PubMed ID: 32263505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.
    Pillai G; Ceballos-Coronel ML
    SAGE Open Med; 2013; 1():2050312113513759. PubMed ID: 26770691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
    Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models.
    Petrikaite V; D'Avanzo N; Celia C; Fresta M
    Drug Resist Updat; 2023 May; 68():100956. PubMed ID: 36958083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer.
    Kalave S; Hegde N; Juvale K
    Curr Pharm Des; 2022; 28(38):3140-3157. PubMed ID: 35366765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine to overcome cancer multidrug resistance.
    Yang X; Yi C; Luo N; Gong C
    Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs.
    Miguel RDA; Hirata AS; Jimenez PC; Lopes LB; Costa-Lotufo LV
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system.
    Sun X; Zhao P; Lin J; Chen K; Shen J
    Cancer Drug Resist; 2023; 6(2):390-415. PubMed ID: 37457134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance: Physiological principles and nanomedical solutions.
    Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
    Beretta GL; Cavalieri F
    Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.